Virus protein ligands, like trimeric spike glycoprotein interact with cellular receptors, such as ACE2, and host proteases, like transmembrane protease serine 2 (TMPRSS2), participate in virus entry by proteolytically activating virus ligands (Sallenave and Guillot, 2020
add on to other therapeutic schemes)
Conversely, inflammatory phyla were notably expanded: Pseudomonadota (Proteobacteria) showed extreme enrichment, suggesting gut inflammation and barrier disruption, while Campylobacterota was significantly increased, consistent with pathobiont overgrowth
Its considered experimental, and its safety and efficacy profiles have not been firmly established through large-scale clinical trials
Recipient-site preconditioning with deferoxamine increases fat graft survival by inducing VEGF and neovascularization in a rat model